Cafepharma Daily Premium (On-Demand) Archive for January, 2019

Click a link below to view the mailing archive as if it had been sent to you.

2019-01-31 13:50CP Thu Premium: Can Allergan's Botox hold its own in the migraine market?
2019-01-30 23:56CP Wed Evening Premium: Digital health and patient adherence
2019-01-30 13:55CP Wed Premium: All eyes on Biogen as Roche Alzheimer's treatment fails
2019-01-29 23:29CP Tue Evening Premium: Drug price hearings on Capitol Hill
2019-01-29 15:27CP Tue Premium: When biotech and fintech work together
2019-01-29 00:36CP Mon Evening Premium: FDA lays out 2019 strategy
2019-01-28 13:11CP Mon Premium: FDA opens; Imbruvica approval
2019-01-28 00:18CP Sun Premium: Most drug patent challenges in 2018
2019-01-26 23:40CP Sat Premium: CVS won't cover Amgen migraine drug
2019-01-25 23:24CP Fri Evening Premium: AbbVie loses $8B in market cap on Humira erosion
2019-01-25 13:09CP Fri Premium: Cancer setback for Lilly
2019-01-25 00:32CP Thu Evening Premium: BMS earnings
2019-01-24 13:29CP Thu Premium: Alexander Hardy will be GENE's new CEO
2019-01-23 23:58CP Wed Evening Premium: Vertex exec fired over conduct violations
2019-01-23 14:39CP Wed Premium: Senate to hold drug price hearings
2019-01-23 00:28CP Tue Evening Premium: Insulin prices have doubled in four years
2019-01-22 13:05CP Tue Premium: Clinical trial news + JNJ earnings
2019-01-21 12:46CP Mon Premium: Funding for antibiotic resistance solutions
2019-01-20 22:27CP Sun Premium: Gene editing and the FDA
2019-01-19 18:38CP Sat Premium: What drug approvals may be stopped by the shutdown?
2019-01-18 21:49CP Fri Evening Premium: Big Pharma worrying less about Amazon?
2019-01-18 12:52CP Fri Premium: Lartruvo setback deals a blow to Lilly's oncology hopes
2019-01-18 00:15CP Thu Evening Premium: Breast cancer drug regulatory decisions
2019-01-17 11:51CP Thu Premium: The Lilly-Loxo Oncology deal was put together in 10 days
2019-01-17 00:10CP Wed Evening Premium: Amgen's osteoporosis drug gets panel vote
2019-01-16 12:32CP Wed Premium: Trump administration throws down drug price gauntlet
2019-01-16 00:33CP Tue Evening Premium: Purdue Pharma, Shingrix shortage, and more
2019-01-15 12:38CP Tue Premium: FDA reviews running on fumes
2019-01-15 00:06CP Mon Evening Premium: Merck's Keytruda esophageal cancer victory
2019-01-14 13:05CP Mon Premium: The latest biotech IPOs
2019-01-12 20:57CP Sat Premium: Who are Lilly, Pfizer, and Biogen looking to make deals with
2019-01-12 00:57CP Fri Evening Premium
2019-01-11 13:41CP Fri Premium: Goodbye to San Fran and JPMHC 2019
2019-01-11 00:31CP Thu Evening Premium: JPM -- Sage, Mersana, shutdown woes
2019-01-10 13:56CP Thu Premium: JPMorgan Healthcare Conference's last day
2019-01-10 00:20CP Wed Evening Premium: Novartis sales reps using AI
2019-01-09 13:40CP Wed Premium: JP Morgan R&D debate
2019-01-08 23:47CP Tue Evening Premium: UroGen, Biogen, and more
2019-01-08 11:25CP Tue Premium: Merck and a new FDA innovation office
2019-01-08 00:49CP Mon Evening Premium: JPMHC: What Pfizer and Bristol-Myers said
2019-01-07 12:25CP Mon Premium: JP Morgan kicks off with Lilly-Loxo Oncology deal
2019-01-06 23:13CP Sun Premium: Is the BMS acquisition a bad deal for Celgene?
2019-01-05 15:09CP Sat Premium: More on the JPMHC conference
2019-01-05 00:16CP Fri Evening Premium: Still more BMS-Celgene news
2019-01-04 13:32CP Fri Premium: What to watch for at JP Morgan Healthcare
2019-01-03 23:55CP Thu Evening Premium: More analysis of BMS-Celgene
2019-01-03 13:51CP Wed Premium: Bristol-Myers to buy Celgene in first big deal of the year
2019-01-02 21:51CP Wed Evening Premium: Key themes for pharma in 2019
2019-01-02 12:15CP Wed Premium: IPOs, price hikes, and more

 

<< Archive IndexSubscribe >>

Contact Us

Past Issues

Unsubscribe